Published in Neuroscience on April 08, 2008
Functions of S100 proteins. Curr Mol Med (2013) 2.43
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res (2010) 2.19
Cranial irradiation alters the brain's microenvironment and permits CCR2+ macrophage infiltration. PLoS One (2014) 1.01
Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA. J Neurochem (2009) 0.93
Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes. Eur Arch Psychiatry Clin Neurosci (2011) 0.88
Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B. Int Immunol (2011) 0.87
S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance. Cardiovasc Psychiatry Neurol (2010) 0.86
Blood biomarkers for brain injury: What are we measuring? Neurosci Biobehav Rev (2016) 0.80
Chronic fluoxetine treatment changes S100B expression during postnatal rat brain development. J Child Adolesc Psychopharmacol (2013) 0.79
S100b counteracts neurodegeneration of rat cholinergic neurons in brain slices after oxygen-glucose deprivation. Cardiovasc Psychiatry Neurol (2010) 0.76
Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia-A Meta-Regression Analysis. Front Cell Neurosci (2016) 0.76
Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci (1993) 3.79
Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am J Neuroradiol (1992) 2.58
Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord (1999) 2.46
Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke (2000) 2.09
[Sadistic fetishism--deadly passion. Forensic psychiatric assessment of sex offenders]. Nervenarzt (2008) 2.02
Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci (1999) 1.90
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry (1999) 1.61
Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience (2004) 1.57
Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res (1998) 1.53
Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. J Infect Dis (1999) 1.53
Demonstration of immunochemical identity between the nerve growth factor-inducible large external (NILE) glycoprotein and the cell adhesion molecule L1. EMBO J (1985) 1.46
Three-dimensional fast low-angle shot imaging and computerized volume measurement of the hippocampus in patients with chronic epilepsy of the temporal lobe. AJNR Am J Neuroradiol (1991) 1.43
Identification of a biological signature for schizophrenia in serum. Mol Psychiatry (2011) 1.43
[Subjective experience and neuronal integration in the brain: do we need a first-person neuroscience?]. Fortschr Neurol Psychiatr (2006) 1.40
Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell (2000) 1.39
Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry (1985) 1.35
Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study. Am J Psychiatry (2000) 1.30
Functional dissociation between medial and lateral prefrontal cortical spatiotemporal activation in negative and positive emotions: a combined fMRI/MEG study. Cereb Cortex (2000) 1.29
Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology (Berl) (1999) 1.28
Nerve growth factor-inducible large external (NILE) glycoprotein: studies of a central and peripheral neuronal marker. J Neurosci (1983) 1.23
Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci (1986) 1.23
Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry (1994) 1.23
The role of cAMP in nerve growth factor-promoted neurite outgrowth in PC12 cells. J Cell Biol (1986) 1.22
Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia. Psychol Med (2009) 1.21
Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry (1995) 1.21
Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study. Schizophr Res (1992) 1.12
Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry (1999) 1.12
Limbic pathology in schizophrenia: the entorhinal region--a morphometric study. Biol Psychiatry (1988) 1.11
A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry (1983) 1.10
Cell surface Thy-1-cross-reactive glycoprotein in cultured PC12 cells: modulation by nerve growth factor and association with the cytoskeleton. J Neurosci (1985) 1.09
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett (1999) 1.08
Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res (1992) 1.07
2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett (1997) 1.07
Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke (2000) 1.06
Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study. Schizophr Res (1995) 1.03
Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: first experience with three cases. Pharmacopsychiatry (2009) 1.02
Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry (2006) 1.02
Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma (2000) 1.01
Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution. Glia (1999) 1.01
Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem (1999) 1.00
Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry (1992) 1.00
Redundancy of class III POU proteins in the oligodendrocyte lineage. J Biol Chem (1997) 1.00
Stress proteins in oligodendrocytes: differential effects of heat shock and oxidative stress. J Neurochem (2001) 1.00
Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience (1998) 1.00
Gliosis in schizophrenia: a survey. Biol Psychiatry (1986) 0.99
Cerebellar volume asymmetries are related to handedness: a quantitative MRI study. Neuropsychologia (1995) 0.99
Comparison of different biogenic matrices seeded with cultured Schwann cells for bridging peripheral nerve defects. Neurol Res (2004) 0.98
Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology (1999) 0.98
High field FMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei. Front Neuroanat (2010) 0.97
Is our self based on reward? Self-relatedness recruits neural activity in the reward system. Neuroimage (2007) 0.97
Nardilysin in human brain diseases: both friend and foe. Amino Acids (2013) 0.97
Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry (1992) 0.96
Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease? Psychol Med (1997) 0.96
Expression of Krox proteins during differentiation of the O-2A progenitor cell line CG-4. J Neurochem (1997) 0.96
The brains of the Vogt collection. Arch Gen Psychiatry (1988) 0.95
Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol (1999) 0.94
Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord (2001) 0.94
The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr Res (1999) 0.94
13C isotopomer analysis of glucose and alanine metabolism reveals cytosolic pyruvate compartmentation as part of energy metabolism in astrocytes. Glia (2001) 0.94
Cerebral volume asymmetries in schizophrenia and mood disorders: a quantitative magnetic resonance imaging study. Int J Psychophysiol (1999) 0.93
Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience (2010) 0.93
Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr Res (1995) 0.93
WHODAS II with people after stroke and their relatives. Disabil Rehabil (2009) 0.92
Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophr Bull (1992) 0.92
Elevated S100B levels in schizophrenia are associated with insulin resistance. Mol Psychiatry (2010) 0.92
Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res (1998) 0.91
Circumscribed numerical deficit of dorsal raphe neurons in mood disorders. Psychol Med (2002) 0.91
Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology (Berl) (1999) 0.91
Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria. FASEB J (2001) 0.90
Density of trunk tissues of young and medium age people. J Biomech (1990) 0.90
Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance. J Neural Transm Gen Sect (1995) 0.90
Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia (2001) 0.89
No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol (1999) 0.89
[Use of the WHODAS II with stroke patients and their relatives: reliability and inter-rater-reliability]. Rehabilitation (Stuttg) (2008) 0.89
Identification of tubulin associated with rat brain myelin. FEBS Lett (1978) 0.89
Absence of the adhesio interthalamica as a marker of early developmental neuropathology in schizophrenia: an MRI and postmortem histologic study. J Neuroimaging (1998) 0.89
The narcissistic self and its psychological and neural correlates: an exploratory fMRI study. Psychol Med (2010) 0.89
Prevention of free fatty acid-induced lipid accumulation, oxidative stress, and cell death in primary hepatocyte cultures by a Gynostemma pentaphyllum extract. Phytomedicine (2012) 0.89
A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Mol Psychiatry (2008) 0.88
Tissue engineering of peripheral nerves: Epineurial grafts with application of cultured Schwann cells. Microsurgery (2003) 0.88
Revascularization of tissue-engineered nerve grafts and invasion of macrophages. Tissue Eng (2001) 0.88
Metabolism of acetate in rat brain neurons, astrocytes and cocultures: metabolic interactions between neurons and glia cells, monitored by NMR spectroscopy. Cell Mol Biol (Noisy-le-grand) (1997) 0.88
Fewer beta-endorphin expressing arcuate nucleus neurons and reduced beta-endorphinergic innervation of paraventricular neurons in schizophrenics and patients with depression. Cell Mol Biol (Noisy-le-grand) (2002) 0.88
In vitro phosphorylation of microtubule-associated protein 2: differential effects of cyclic AMP analogues. J Neurochem (1985) 0.87
Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections. Acta Neurol Scand (2005) 0.87
Tissue engineering of peripheral nerves: A comparison of venous and acellular muscle grafts with cultured Schwann cells. Plast Reconstr Surg (2001) 0.87
Protection of primary glial cells by grape seed proanthocyanidin extract against nitrosative/oxidative stress. Nitric Oxide (2001) 0.87
The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains. Neuropathol Appl Neurobiol (2005) 0.87
Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Transl Psychiatry (2012) 0.86